MedTrace Logo

The Optimal Dosage of Intrathecal Morphine for Peripartum Analgesia

NCT01146457 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2017-04-25

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the ideal dosage of intrathecal morphine for intra and post partum analgesia, while minimizing the side effect profile.

Conditions

  • Labor Pain

Interventions

DRUG

Morphine

Active dosage

DRUG

Saline

Saline Control

Sponsors & Collaborators

Principal Investigators

  • Philip E Hess, MD · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01146457 on ClinicalTrials.gov